Clinical experience with post-orgasmic illness syndrome (POIS) patients—characteristics and possible treatment modality

Abstract

Post-orgasmic illness syndrome (POIS) is a rare condition that includes a cluster of post-ejaculatory symptoms with debilitating physical and psychological consequences. The prevalence and incidence of POIS remain unknown as well as the pathophysiology of the syndrome, and there are no well-studied recognized treatment modalities. The current retrospective observational study describes a series of 14 highly selected patients who were actively looking for medical help as POIS has a significant effect on patients and their partners. The aim is to increase knowledge about this syndrome and possible treatment modality. According to a standard protocol, patients have been systematically interviewed, had a physical examination, laboratory blood tests, and treatments. Mean age was 34.07 ± 6.65 years. The majority of patients had only one symptom in common—extreme fatigue. The most prevalent complaints were head pressure/heaviness, nose congestion and muscle tension; all patients suffered from more than 1 symptom. POIS started on average within 30 min of ejaculation and lasted for 3.5 days. The patients reported emotional and psychosocial burden of their symptoms, which also influence their partner and relationships. Immunoglobulin-E measurements did not show elevated levels and/or significant increase within 24 h after ejaculation. Silodosin, a highly selective alpha1A-blocker, which actually causes anejaculation, was effective treatment in 57% of the patients.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Flow diagram of treatment modalities used.

References

  1. 1.

    Waldinger MD, Schweitzer DH. Post orgasmic illness syndrome: two cases. J Sex Marital Ther. 2002;28:251–5.

    Article  Google Scholar 

  2. 2.

    Waldinger MD. Post orgasmic illness syndrome (POIS). Transl Androl Urol. 2016;5:602–6. https://doi.org/10.21037/tau.2016.07.01

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Nguyen HMT, Bala A, Andrew T, Gabrielson AT, Hellstrom WJG. Post-orgasmic illness syndrome: a review. Sex Med Rev. 2018;6:11–15. https://doi.org/10.1016/j.sxmr.2017.08.006

    Article  PubMed  Google Scholar 

  4. 4.

    Waldinger MD, Meinardi MM, Zwinderman AH, Schweitzer DH. Postorgasmic illness syndrome (POIS) in 45 Dutch Caucasian males: clinical characteristics and evidence for an immunogenic pathogenesis. J Sex Med. 2011;8(part 1):1164–70. https://doi.org/10.1111/j.1743-6109.2010.02166.x

    Article  PubMed  Google Scholar 

  5. 5.

    Jiang N, Xi G, Li H, Yin J. Postorgasmic illness syndrome (POIS) in a Chinese man: no proof for IgE-mediated allergy to semen. J Sex Med. 2015;12:840–5. https://doi.org/10.1111/jsm.12813

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Le TV, Nguyen HMT, Hellstrom WJG. Postorgasmic illness syndrome: what do we know so far? J Rare Dis Res Treat. 2018;3:29–33.

    Article  Google Scholar 

  7. 7.

    Ashby J, Goldmeier D. Postorgasm illness syndrome–a spectrum of illnesses. J Sex Med. 2010;7:1976–81. https://doi.org/10.1111/j.1743-6109.2010.01707.x

    Article  PubMed  Google Scholar 

  8. 8.

    Waldinger MD, Meinardi MMHM, Schweitzer DH. Hyposensitization therapy with autologous semen in two Dutch Caucasian males: beneficial effects in postorgasmic illness syndrome (POIS; Part 2). J Sex Med. 2011;8:1171–6. https://doi.org/10.1111/j.1743-6109.2010.02167.x

    Article  PubMed  Google Scholar 

  9. 9.

    Strashny A. First assessment of the validity of the only diagnostic criteria for postorgasmic illness syndrome (POIS). Int J Impot Res. 2019;31:369–73. https://doi.org/10.1038/s41443-019-0154-7

    Article  PubMed  Google Scholar 

  10. 10.

    Bignami B, Honore T, Turmel N, Haddad R, Weglinski L, Le Breton F, et al. Post orgasmic illness syndrome. Prog Urol 2017;27:446–9. https://doi.org/10.1016/j.purol.2017.03.007

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Mashal A, Beer S. Post orgasmic illness. J Sex Med. 2016;13:S199. https://doi.org/10.1016/j.jsxm.2016.03.271

    Article  Google Scholar 

  12. 12.

    Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-art review. Int J Impot Res. 2002;14:226–44.

    CAS  Article  Google Scholar 

  13. 13.

    Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale; preliminary report. Psychopharmacol Bull. 1973;9:13–28.

    CAS  PubMed  Google Scholar 

  14. 14.

    Amarasekera A. Immunoglobulin E in health and disease. Asia Pac Allergy. 2011;1:12–15. https://doi.org/10.5415/apallergy/2011.1.1.12

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Kobayashi K, Masumori N, Hisasue S, Kato R, Hashimoto K, Itoh N, et al. Inhibition of seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers. J Sex Med. 2008;5:2185–90. https://doi.org/10.1111/j.1743-6109.2008.00779.x

    Article  PubMed  Google Scholar 

  16. 16.

    U.S. Department of Health & Human Services. National Institutes of Health. Genetic and rare diseases information center, 2020.https://rarediseases.info.nih.gov/diseases/10809/postorgasmic-illness-syndrome.

  17. 17.

    POIS Center.com. Post orgasmic illness syndrome (P.O.I.S.): Statistics Center, 2019. https://poiscenter.com/forums/index.php?action=stats.

  18. 18.

    Naked Science Forum©. The Naked Scientists.com, Post orgasmic illness syndrome (POIS). https://www.thenakedscientists.com/forum/index.php?topic=6576.0, accessed February 20, 2020.

  19. 19.

    Facebook.com. Private Group. Post orgasmic illness syndrome (POIS). https://www.facebook.com/groups/1457009341209480/, accessed February 20, 2020.

  20. 20.

    Shigeta K, Kikuchi E, Matsushima M, Daimon T, Yazawa S, Ando T, et al. A clinical case of suspected postorgasmic illness syndrome. J Sex Med. 2013;10 Supp 3:220.

    Google Scholar 

  21. 21.

    Saitz TR, Serefoglu EC. The epidemiology of premature ejaculation. Transl Androl Urol. 2016;5:409–15. https://doi.org/10.21037/tau.2016.05.11

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Kim T, Shim Y, Lee S, Son ES, Shim JW, Lee SP. Intralymphatic immunotherapy with autologous semen in a Korean man with post-orgasmic illness syndrome. Sex Med. 2018;6:174–9. https://doi.org/10.1016/j.esxm.2017.12.004

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Diaz RC, Liang J, Hallet L, Meyers AD. Diagnostic allergy testing: specific IgE testing. Medscape. 2016.

  24. 24.

    Abdessater M, Elias S, Mikhael E, Alhammadi A, Beley S. Post orgasmic illness syndrome: what do we know till now? Basic Clin Androl. 2019;29:13. https://doi.org/10.1186/s12610-019-0093-7

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Y. Reisman.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Reisman, Y. Clinical experience with post-orgasmic illness syndrome (POIS) patients—characteristics and possible treatment modality. Int J Impot Res (2020). https://doi.org/10.1038/s41443-020-0314-9

Download citation